PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3- kinase in mesangial cells  Jian Yao, Tetsuo Morioka, Takashi Oite  Kidney.

Slides:



Advertisements
Similar presentations
Proinflammatory cytokine–induced and chemical mediator–induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein.
Advertisements

Volume 56, Issue 5, Pages (November 1999)
Volume 124, Issue 7, Pages (June 2003)
Volume 68, Issue 4, Pages (October 2005)
Volume 114, Issue 4, Pages (April 1998)
Vascular Endothelial–Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues by Nathalie Lambeng, Yann Wallez, Christine Rampon, Francine.
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 66, Issue 4, Pages (October 2004)
Volume 62, Issue 3, Pages (September 2002)
Volume 53, Issue 5, Pages (May 1998)
Phosphoinositide 3-kinase inhibitors protect mouse kidney cells from cyclosporine- induced cell death  E. Sarró, O. Tornavaca, M. Plana, A. Meseguer, E.
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 61, Issue 2, Pages (February 2002)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 60, Issue 3, Pages (September 2001)
Volume 63, Issue 2, Pages (February 2003)
Volume 114, Issue 4, Pages (April 1998)
Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes  Huiquan Lou, Kuljeet Kaur, Anita K. Sharma, Pawan.
Volume 60, Issue 2, Pages (August 2001)
by Xingwei Sui, Sanford B. Krantz, Min You, and Zhizhuang Zhao
Volume 66, Issue 5, Pages (November 2004)
Volume 60, Issue 5, Pages (November 2001)
Istvan Arany, Judit K. Megyesi, Jane E.B. Reusch, Robert L. Safirstein 
Volume 65, Issue 5, Pages (May 2004)
Volume 122, Issue 5, Pages (May 2002)
Volume 65, Issue 4, Pages (April 2004)
Mechanical stretch induces podocyte hypertrophy in vitro1
Volume 62, Issue 4, Pages (October 2002)
Volume 56, Issue 5, Pages (November 1999)
Angiotensin II-induced growth of vascular smooth muscle cells requires an Src- dependent activation of the epidermal growth factor receptor1  Dirk Bokemeyer,
Volume 68, Issue 3, Pages (September 2005)
Hyaluronan and proximal tubular cell migration
Volume 68, Issue 1, Pages (July 2005)
Volume 56, Issue 4, Pages (October 1999)
Volume 64, Issue 4, Pages (October 2003)
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Volume 118, Issue 6, Pages (June 2000)
STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells  I. Arany, J.K. Megyesi, B.D. Nelkin,
Volume 65, Issue 6, Pages (June 2004)
Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERK  Richard J. Dixon, Nigel J. Brunskill 
Tyrosine Phosphorylation of Human Keratinocyte β-Catenin and Plakoglobin Reversibly Regulates their Binding to E-Cadherin and α-Catenin  Peiqi Hu, Edward.
Volume 63, Issue 2, Pages (February 2003)
Volume 68, Issue 4, Pages (October 2005)
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
Volume 58, Issue 3, Pages (September 2000)
Volume 64, Issue 1, Pages (July 2003)
Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP- kinase–dependent process  Marjorie E. Dunlop, Ph.D., Evelyne E. Muggli 
Volume 60, Issue 6, Pages (December 2001)
Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts  A. Graness, I. Cicha, M. Goppelt-Struebe 
Volume 68, Issue 2, Pages (August 2005)
Volume 62, Issue 2, Pages (August 2002)
Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells  Gur P. Kaushal, Varsha Kaushal, Ph.D., Xiaoman.
Volume 61, Issue 6, Pages (June 2002)
Growth hormone reduces chloride secretion in human colonic epithelial cells via EGF receptor and extracellular regulated kinase1   Jimmy Y.C Chow, Katie.
Differential Regulation of Cyclooxygenase-2 Expression by Phytosphingosine Derivatives, NAPS and TAPS, and its Role in the NAPS or TAPS-Mediated Apoptosis 
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Role of c-SRC and ERK in acid-induced activation of NHE3
Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress  Marjorie E. Dunlop,
Volume 60, Issue 3, Pages (September 2001)
Volume 70, Issue 5, Pages (September 2006)
Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): Mechanism of cyclosporine A–induced increase in transepithelial.
Volume 58, Issue 1, Pages (July 2000)
Cultured human glomerular mesangial cells express the C5a receptor
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
CML-HSA treatment activates MAPK family members ERK1/2 and p38 but not JNK. Samples were taken at the indicated times after 100 μg/ml CML-HSA exposure.
Larry D. Alexander, Suganthi Alagarsamy, Janice G. Douglas 
Presentation transcript:

PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3- kinase in mesangial cells  Jian Yao, Tetsuo Morioka, Takashi Oite  Kidney International  Volume 57, Issue 5, Pages 1915-1926 (May 2000) DOI: 10.1046/j.1523-1755.2000.00041.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Presence and localization of connexin43 (Cx43) in mesangial cell (MC) monolayers. Immunofluorescent staining of cultured MCs with monoclonal anti-Cx43 antibody. Note the characteristic spotted staining of Cx43 at cell–cell contact areas (magnification ×400). Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Lucifer yellow diffusion from microinjected MCs. Lucifer yellow was pressure injected, together with ethidium bromide, into a single MC in a monolayer. Lucifer yellow diffusion into adjacent cells was monitored over a three-minute time period. (Upper panels) MCs without pretreatment with PDGF. (Lower panels) MCs pretreated with PDGF for 15 minutes before injection. (A andD) Phase-contrast micrographs. (B andE) Lucifer yellow fluorescence. (C andF) Ethidium bromide staining of the microinjected cell (magnification ×320). The arrow indicates the microinjected cell. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Time course of platelet-derived growth factor (PDGF)-induced disruption of gap junctional intercellular communication (GJIC) in cultured MCs. Confluent MCs were treated with PDGF (10 ng/mL) for the indicated lengths of time. GJIC was assessed by Lucifer yellow microinjection into single cell. Data points represent the mean ± SD of cells (N = 10) to which Lucifer yellow was transferred from the injected cell within three minutes. Similar results were obtained in two additional experiments. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Prevention of PDGF-induced disruption of GJIC by PI3K inhibitor LY294002. Confluent MCs were pretreated with either 100 μmol/L of LY294002 or were left untreated before exposure to 10 ng/mL of PDGF for 15 minutes. GJIC was assessed by Lucifer yellow microinjection into a single cell. Data points represent the mean ± SD of the number of cells (N = 10) to which Lucifer yellow was transferred from the injected cells within three minutes of injection. *P < 0.01 vs. control; #P < 0.01 vs. PDGF alone. Similar results were obtained in two additional experiments. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Time- and dose-dependent induction of tyrosine phosphorylation of Cx43 protein by PDGF in MCs. Confluent MCs were treated with PDGF (10 ng/mL) for the lengths of time indicated (A) or with indicated concentrations of PDGF (B) for 15 minutes. Cellular proteins were then harvested and immunoprecipitated with anti-Cx43 antibody (A, monoclonal anti-Cx43;B, polyclonal rabbit anti-Cx43 antibody). After SDS-polyacrylamide gel electrophoresis and transfer to PVDF, blots were probed with antityrosine mAb PY20 (left) or stripped and reprobed with anti-Cx43 antibody (right) to verify that the difference in tyrosine phosphorylation of Cx43 was not due to differences in the loading of proteins. Blots shown are from one representative experiment from a series of three with similar results. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Prevention of PDGF-induced tyrosine phosphorylation of Cx43 by PI3K inhibitors. (A) Confluent MCs were exposed to PDGF (10 ng/mL) for 15 minutes with or without the pretreatment with 100 μmol/L LY294002. Cellular proteins were then harvested and immunoprecipitated with a monoclonal anti-Cx43 antibody. After SDS-polyacrylamide gel electrophoresis and transfer to PVDF, blots were probed with antityrosine mAb PY20 (left) or stripped and reprobed with a monoclonal anti-Cx43 antibody (right) to verify that the difference in tyrosine phosphorylation of Cx43 was not due to differences of the proteins loaded. Similar results were obtained in two additional experiments. (B) Densitometric analysis of the Western blots. Results are expressed as arbitrary unit calculated from the ratio of the densitometric values of phosphotyrosine to Cx43 protein for each treatment. (C) MCs were pretreated with or without the indicated concentrations of LY294002 before exposure to PDGF (10 ng/mL) for 15 minutes. Phosphorylation of Cx43 was detected as described in this article. A similar result was obtained in an additional experiment. (D) Densitometric analysis of Western blot C. Results are expressed as percentage of control without pretreatment of LY294002. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 7 Activation of extracellular signal-regulated kinase (ERK) by PDGF. Confluent MCs were treated with PDGF (10 ng/mL) for the indicated lengths of time (left) or with the indicated concentrations of PDGF (right) for five minutes. Cellular proteins were then harvested and analyzed by Western blot with either antiphosphorylated ERK (pERK) antibody (A) or anticontrol MAPK antibody (B). Two additional experiments done with the same schedule showed a similar result. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 8 PI3K inhibitors inhibit PDGF-induced activation of extracellular signal-regulated kinase (ERK). Confluent MCs were exposed to PDGF (10 ng/mL) for 10 minutes with or without pretreatment with 100 μmol/L LY294002 (A) or the indicated concentrations of wortmanin (B). Cellular proteins were then harvested and analyzed by Western blot with a phosphorylated ERK (pERK) antibody. Similar results were obtained in three additional experiments. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 9 Induction of tyrosine phosphorylation of Cx43 by tyrosine phosphatase inhibitor PAO. Confluent MCs were either left untreated (lane 1) or treated with 5 μmol/L PAO (lane 2), 0.05% dimethyl sulfoxide control (lane 3), or 10 ng/mL PDGF (lane 4) for 15 minutes. Cellular proteins were then harvested and immunoprecipitated with polyclonal rabbit anti-Cx43 antibody. After SDS-polyacrylamide gel electrophoresis and transfer to PVDF, blot was probed with antityrosine mAb PY20 (A) or stripped and reprobed with anti-Cx43 antibody to verify that the difference in tyrosine phosphorylation of Cx43 was not due to differences in the loading of proteins (B). Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 10 Disruption of GJIC by the tyrosine phosphatase inhibitor PAO. Confluent MCs were treated with either PAO (5 μmol/L) or PDGF (10 ng/mL) for 15 minutes. GJIC was assessed by Lucifer yellow microinjection into a single cell. Data points represent the mean ± SD of the number of cells (N = 10) to which Lucifer yellow was transferred from the injected cells within three minutes of injection. *P < 0.01 vs. control. Similar results were obtained in an additional experiment. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 11 Prevention of PDGF-induced activation of MAPK and disruption of GJIC by MEK inhibitor PD98059. (A) Confluent MCs were exposed to PDGF (10 ng/mL) for 15 minutes with or without pretreatment with PD98059. Cellular proteins were then harvested and analyzed by Western blot with either antiphosphorylated ERK (pERK) antibody (A, left) or anticontrol ERK antibody (A, right). (B) Confluent MCs were pretreated with 100 μmol/L of PD98059 for one hour or left untreated before exposure to 10 ng/mL of PDGF for 15 minutes. GJIC was assessed by Lucifer yellow microinjection into a single cell. Data points represent the mean ± SD of the number of cells (N = 10 to 14) to which Lucifer yellow was transferred from the injected cells within three minutes of injection. *P < 0.01 vs. control; #P < 0.01 vs. PDGF-treated cells. Similar results were obtained in an additional experiment. Kidney International 2000 57, 1915-1926DOI: (10.1046/j.1523-1755.2000.00041.x) Copyright © 2000 International Society of Nephrology Terms and Conditions